Lack of value of routine postpartum hematocrit determination after vaginal delivery

被引:21
作者
Nicol, B
CroughanMinihane, M
Kilpatrick, SJ
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT FAMILY & COMMUNITY MED, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, DEPT BIOSTAT & EPIDEMIOL, SAN FRANCISCO, CA 94143 USA
关键词
D O I
10.1016/S0029-7844(97)00354-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To identify risk factors associated with low postpartum hematocrits after vaginal delivery and to define lower risk categories of patients for whom routine determination of hematocrit may not be necessary. Methods: This case-control study was designed to identify risk factors for discharge hematocrit below 27% in nonanemic patients after a vaginal delivery using the University of California, San Francisco, Perinatal Database, Multivariate statistics were used to determine the most significant risk factors. Lower risk subpopulations were analyzed to determine their rate of low discharge hematocrits. Results: Risk factors associated with odds Patios greater than 1.5 for discharge hematocrit less than 27% included estimated blood loss greater than 500 mt, placenta previa, abruption, prolonged third stage, preeclampsia, prior postpartum hemorrhage, and prior cesarean delivery. Estimated blood loss > 500 mt was the most significant risk factor for discharge hematocrit less than 27% (odds ratio 4.5, 95% confidence interval 3.8, 5.4). A population without statistically significant risk factors was identified; this group had a 1.4% risk of discharge hematocrit less than 27%. Conclusion: Routine postpartum hematocrits are unnecessary in clinically stable patients with an estimated blood loss of less than 500 mt. (C) 1997 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:514 / 518
页数:5
相关论文
共 11 条
[1]  
COMBS CA, 1991, OBSTET GYNECOL, V77, P69
[2]  
CRAWFORD M. D., 1940, Journal of Obstetrics and Gynaecology of the British Empire, V47, P63
[3]  
FREEMAN RK, 1992, ACOG GUIDELINES PERI, P107
[4]  
GAHRES EE, 1962, OBSTET GYNECOL, V19, P455
[5]  
HEMMINKI E, 1991, J AM COLL NUTR, V10, P3
[6]  
Hiss RG, 1986, BLOOD DISORDERS PREG, P1
[7]  
NEWTON M, 1961, OBSTET GYNECOL, V17, P9
[8]   THE BRISTOL 3RD STAGE TRIAL - ACTIVE VERSUS PHYSIOLOGICAL MANAGEMENT OF 3RD STAGE OF LABOR [J].
PRENDIVILLE, WJ ;
HARDING, JE ;
ELBOURNE, DR ;
STIRRAT, GM .
BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6659) :1295-1300
[9]  
PRITCHARD JA, 1962, AM J OBSTET GYNECOL, V84, P1271
[10]   RED-CELL MASS DURING AND AFTER NORMAL-PREGNANCY [J].
TAYLOR, DJ ;
LIND, T .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1979, 86 (05) :364-370